ESCMID Conference on the Impact of Vaccines on Public Health
1 - 3 April 2011, Prague, Czech Republic
Conference Objectives
As part of its multifaceted approach to infections, ESCMID strives to promote vaccination and worries that the current lack of correct information among both lay public and health care providers might seriously undermine the efficacy of current and future vaccine campaigns.
This conference will bring together world-leading experts to debate the many-sided correlations between vaccines, medicine and society at the dawn of the third millennium.
Supported by:
The Lancet Infectious Diseases
In cooperation with
European Respiratory Society (ERS)
European Society for Paediatric Infectious Diseases (ESPID)
Global Chinese Association of Clinical Microbiology and Infectious Diseases (GCACMID)
Infectious Diseases Society of America (IDSA)
International Society of Chemotherapy (ISC)
International Society for Infectious Diseases (ISID)
Acknowledgements
ESCMID would like to acknowledge the contribution of Merck, Novartis and Pfizer through unrestricted educational grants.
Conference Material
Webcasts of the conference are available in the ESCMID Online Lecture Library
Friday, 1 April 2011
The Current Landscape | |
|---|---|
The role of the WHO-Europe. Nedret Emiroglu | |
The role of the ECDC. Marc Sprenger, Director | |
The enduring threat of infectious diseases. Alasdair Geddes | |
Measuring the impact of vaccines on the burden of disease in the population. Kathryn M. Edwards |
Vaccines for Children | |
|---|---|
The value of vaccines in paediatrics. Fred Zepp | |
Rotaviruses vaccination: a worldwide perspective. Timo Vesikari | |
Neonatal meningitis: Group B strep. Paul Heath | |
Vaccines for mothers and children: maternal immunisation. Susanna Esposito |
Vaccines Facing the Problems of the XXI Century | |
|---|---|
Vaccines and vaccine-preventable diseases in international travellers. | |
Vaccination and natural disasters. Michel Van Herp | |
Vaccines boost the economies of poor countries. David Bloom No material available | |
Immunisations against bioterrorism: smallpox and anthrax. Wendy Keitel |
Pneumococcal Disease | |
|---|---|
Understanding the burden of pneumococcal disease in adults. Francesco Blasi | |
Pneumococcal infection management in the AR era. Tobias Welte | |
Pneumococcal vaccines for children: why to recommend it? | |
The role of pneumococcal vaccination in prevention of influenza-associated morbidity. Keith Klugman |
Saturday, 2 April 2011
Influenza | |
|---|---|
Pandemic flu and the anti-H1N1 vaccine, a retrospective view. | |
Compliance with anti-H1N1 vaccine among HCW and general population. Francesco Blasi | |
Children and flu. Susanna Esposito | |
Optimising flu recommendations: the European view. Angus Nicoll |
Vaccines for Special Patients | |
|---|---|
Vaccines for the elderly. Birgit Weinberger | |
HPV vaccination and primary prevention of cervical cancer. Mario Poljak | |
Vaccination of immunocompromised patients. Per Ljungman | |
Update on pertussis at the extremes of ages. Kathryn M. Edwards |
Vaccines, Media and Community | |
|---|---|
Global safety of vaccines: strengthening systems for monitoring and management. Hanna Nohynek | |
Monitoring and assessing vaccine safety: a European perspective. | |
Harmonisation of vaccination policy across region. Pierluigi Lopalco |
Meningococcal Disease: Recent Developments and Novel Challenges | |
|---|---|
International epidemiology of meningococcal disease and the unmet need for vaccines. Pavla Krizova | |
The pathogenesis of meningococcal disease and implications for vaccine development. Richard Moxon | |
Impact of Serogroup A, C, W135 and Y vaccines and the influence of formulation and boosting. Jamie Findlow | |
Recent data from clinical trials of novel serogroup B vaccines. Matthew Snape |
Vaccinology, an Evolving Science | |
|---|---|
The vaccine production process: Hi-Tech development for modern vaccinology. Rino Rappuoli | |
Vaccine administration routes and novel delivery technology. Fabienne Anjuère No material available | |
Vaccine adjuvant as immunological drivers. Giuseppe Del Giudice No material available |
Sunday, 3 April 2011
The History of Vaccination - 4th International Day for Fighting Infection | |
|---|---|
From Jenner to smallpox eradication. Alasdair Geddes No material available | |
Louis Pasteur. Patrick Berché No material available | |
Vaccines to prevent Haemophilus influenzae type b diseases. Richard Moxon |
The history of pneumococcal vaccination. Keith Klugman | |
Global eradication of poliomyelitis. Donato Greco | |
Maurice Hilleman and the MMR vaccine. Barbara Kuter | |
Reverse vaccinology: developing vaccines in the era of genomics. |
Big Challenges and Unmet Needs | |
|---|---|
Measles still spreads in Europe: who is responsible for the failure to vaccinate? Pierluigi Lopalco | |
Polio, between eradication and resurgence. Donato Greco | |
A vaccine for HIV. Barbara Ensoli | |
The malaria vaccine pipeline. Joe Cohen |
Target Audience
Specialists or physicians in training in the following disciplines: infectious diseases, clinical microbiology, hygiene, public health, vaccinology and other disciplines dealing with all aspects of vaccination
